English
Español

(805) 483 1185

Participate in a study!

Linkedin-in Instagram Facebook-f
01 Fomat_Logo_Website-min
proud-partner-HCI-V6
  • Home
  • About Us
  • For Sponsors & CROs
    • Services For Sponsors & CROs
    • Our Capabilities
      • eClinical Trials
      • NASH Capabilities
      • COVID Solutions
      • Vaccine Capabilities
  • For Sites
  • For Patients
    • Educational Program
    • Educational Program: Fatty Liver Test
    • Healthy Volunteers
    • About Clinical Trials
      • What are Clinical Trials
      • Why Participate in a Clinical Trial
      • Clinical Trials FAQs
      • Clinical Trials Glossary
    • Active Studies
  • News & Updates
  • Contact FOMAT
  • │Fomat LatAm
  • US Careers

Home » pharma

Posts tagged: pharma

pharma lab-covid 19

Want to reopen your pharma lab amid COVID-19? Consider these strategies first

July 7, 2020
by marketing_fomat Blogs & Updates

COVID-19 has unleashed a logistical conundrum for pharma lab leaders: How do you keep momentum in therapeutics development, when, like all workplaces, most labs have had to either restrict use or close altogether? The answer lies, at least in part, i ...

Read More
1
new-drug-combination-treat-lung-cancer

Novartis’ Lung Cancer Drug Gets European Approval

May 8, 2015
by fomat_medical Blogs & Updates

Novartis' Lung Cancer Drug Gets European Approval   Article taken from http://www.dddmag.com/news/2015/05/novartis-lung-cancer-drug-gets-european-approval Novartis announced that the European Commission has approved Zykadia (ceritinib) to treat adult ...

Read More
0
Tissue Slides.Double_RGB_Original.v5

3 Ways Technology is Changing the Face of Drug Discovery & Development

April 29, 2015
by fomat_medical Blogs & UpdatesClinical TrialsDrug Discovery and Research

While personalized medicine has been a goal for some time, there have been several obstacles. Although there has been an explosion in genomic data, the corresponding clinical utility for this data has been slow to be validated. Data from tissue image ...

Read More
0
World cancer day (February 4). colorful awareness ribbons; blue, red, green, black, grey, white, pink and yellow color for supporting people living and illness. Healthcare and medical concept

Tumor Micro-Environment: Rough for Nanoparticle Cancer Drugs

January 14, 2015
by fomat_medical Blogs & Updates

Nanoparticle drugs—tiny containers packed with medicine and with the potential to be shipped straight to tumors—were thought to be a possible silver bullet against cancer. However new cancer drugs based on nanoparticles have not improved overall sur ...

Read More
0
World cancer day (February 4). colorful awareness ribbons; blue, red, green, black, grey, white, pink and yellow color for supporting people living and illness. Healthcare and medical concept

Targeting Brain Cancer Cells With a Wound-Healing Drug

January 13, 2015
by fomat_medical Blogs & Updates

 At the Virginia Tech Carilion Research Institute, three scientists are planning to create a virus capable of destroying brain cancer. It sounds like the stuff of science fiction, but it isn’t hypothetical – the researchers were recently awarded a g ...

Read More
0
FDA

FDA Endorses First Low Cost Biotech Drug

January 9, 2015
by fomat_medical Blogs & Updates

  Federal health experts have unanimously endorsed a Novartis drug which is expected to become the first lower-cost copy of a biotech drug to reach the U.S. market. A panel of Food and Drug Administration experts ruled that the company's version of N ...

Read More
0
shutterstock_kidneys2

Researchers Find Alternate Drug Therapy Lowers Antibodies

December 24, 2014
by fomat_medical Blogs & Updates

Researchers Find Alternate Drug Therapy Lowers Antibodies  Findings of a three-year clinical trial led by University of Cincinnati (UC) transplant researchers suggest that a novel pre-operative drug therapy reduces antibodies in kidney patients with ...

Read More
1
shutterstock_cancer cells_11

Researchers Map Paths to Cancer Drug Resistance

December 24, 2014
by fomat_medical Blogs & Updates

Researchers Map Paths to Cancer Drug Resistance  A team of researchers led by Duke Cancer Institute has identified key events that prompt certain cancer cells to develop resistance to otherwise lethal therapies By mapping the specific steps that cell ...

Read More
0
pills

Drug Blocks Key Signal in Cancer Growth and Drug Resistance

December 23, 2014
by fomat_medical Blogs & Updates

An experimental cancer drug may block an important driver for the survival, growth and spread of cancer cells.  The first clinical trial of an experimental drug, called pictilisib, found the safety profile to be manageable in cancer patients at dose ...

Read More
0
Adult and child holding kidney shaped paper, world kidney day, National Organ Donor Day, charity donation concept

High Vancomycin Doses Fuel Risk of Kidney Damage in Children

December 23, 2014
by fomat_medical Blogs & Updates

Results of a small Johns Hopkins Children’s Center study show that hospitalized children given high-dose IV infusions of the antibiotic vancomycin to treat drug-resistant bacterial infections face an increased risk for kidney damage — an often rever ...

Read More
0
  • 1
  • 2
  • 3
  • Next
  • Last

Recent Posts

  • FOMAT Medical Research Launches Phase 1 Services, Elevating Site Operations
  • Simon Corman Joins FOMAT to Help Innovate Healthcare Through Diversity
  • Innovating Our Services Alongside Our Ambulance of Research!
  • We are hiring a Project Manager! 
  • National Endometriosis Awareness Month

Categories

  • Aids
  • Allergies | Allergens
  • Alzheimer
  • Blogs & Updates
  • Breast Cancer
  • Cancer
  • Clinical Trials
  • Colds and Flu
  • Company Updates
  • Coronavirus
  • CRO Contract Research Organization
  • Crohn's Disease
  • Diabetes
  • Diseases
  • Disorders
  • Drug Discovery and Research
  • Ebola
  • eClinical Trials
  • Fertility Drugs
  • General
  • Lung Cancer
  • Marijuana
  • Medical Devices
  • Memory Loss
  • News
  • Research Studies
  • Social Media
  • Vaccines
  • Whitepapers

Upcoming Events

SCOPE Summit For Clinical Ops Executives

Feb6th- 9h, 2023

Orlando, FL

Contact Us

FOMAT Medical Research INC,
300 South A Street Suite 201 Oxnard, CA 93030
(805) 483 1185
Trial Information: [email protected]
General Information: [email protected]
  • Review us on Google
  • Review us on Yelp

Site Map | Privacy Policy

Shopping Basket